• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Using Genomic Data for Disease Prevention


A study published in Nature Medicine highlights how genetic data can be translated in disease prevention and evidence-based clinical management.

Scientists at the University of Oxford, in collaboration with the gene sequencing company Illumina, have published results in the journal Nature Genetics that underscore how important whole genome sequencing could prove in preventing disease. For about 60% of patients who had participated in the study, whole genome sequencing diagnosed genetic disorders. Standard genetic tests had failed to do so in those patients.

Convinced of the importance of these results, the UK's National Health Service plans to sequence the genomes of 100,000 patients through the Genomics England programme. The results of the study have translated into the discovery of 10 new disease-causing genes for inherited cancers and blood disorders, epilepsy, and conditions affecting the muscles or development. The authors predict the importance of their study in preventive diagnosis and clinical management.

Read the article on MedicalXpress: http://bit.ly/1K5ZZQp

Related Videos
Video 12 - "Harnessing Indication-Specific Data on Biosimilars"
Video 11 - "An Overview of Biosimilar Extrapolation During FDA Approval"
Video 3 - "Overview of BCG-Unresponsive Bladder Cancer Treatments Landscape"
Video 2 - "Bladder Cancer with FGFR Alterations: THOR-2 Cohort 1 Study at ESMO 2023"
Video 1 - "Biomarkers and Molecular/ Genomic Testing in Genitourinary Cancers"
Related Content
© 2023 MJH Life Sciences
All rights reserved.